首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Effect of oxaliplatin combined with 5-fluorouracil on treatment efficacy of radiotherapy in the treatment of elderly patients with rectal cancer
【2h】

Effect of oxaliplatin combined with 5-fluorouracil on treatment efficacy of radiotherapy in the treatment of elderly patients with rectal cancer

机译:奥沙利铂联合5-氟尿嘧啶对放疗治疗老年直肠癌的疗效

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Efficacy of the combination of oxaliplatin, 5-fluorouracil and radiotherapy on rectal cancer in elderly patients was investigated. Seventy-three elderly patients with rectal cancer confirmed by histopathological examination were randomly divided into 3 groups: oxaliplatin group (25 cases): intravenous infusion of oxaliplatin; fluorouracil group (24 cases): intravenous infusion of fluorouracil; combination group (24 cases), intravenous infusion of oxaliplatin and fluorouracil. All patients were treated with radiotherapy, and efficacy and safety were evaluated after 2 courses of treatment. MTT assay was used to observe the inhibitory effects of the proliferation of human rectal cancer cells. Cell proliferation and sensitization ratios were compared. After 2 courses of treatment, there was no difference in complete remission (CR), partial remission (PR), stable disease (SD), progression disease (PD) and disease control rate (DCR). Remission rate (RR) was higher in the combination group than that in the oxaliplatin and the fluorouracil groups (P<0.05), and there was no difference between the oxaliplatin and the fuorouracil group (P>0.05). Incidence of neutropenia in the combination group was higher than that in the fluorouracil group (P<0.05). OD values of the combination group were lower than those of the oxaliplatin and the fluorouracil groups (P<0.05). Proliferation ability of SW837 cells of the combination group was significantly lower than that of the oxaliplatin and the fluorouracil groups (P<0.05). Intragroup comparison of sensitization ratio showed that sensitization ratios of three groups of cells at 24, 48 and 72 h were all higher than those at 12 h (P<0.05). The combination of oxaliplatin and 5-fluorouracil is safe and effective in the treatment of rectal cancer in elderly patients, and it can be used for sensitization of radiotherapy. So it should be popularized in clinical practices.
机译:研究了奥沙利铂,5-氟尿嘧啶联合放疗对老年患者直肠癌的疗效。经组织病理学检查确诊的73例老年直肠癌患者随机分为3组:奥沙利铂组(25例):静脉输注奥沙利铂;静脉输注奥沙利铂。氟尿嘧啶组(24例):静脉输注氟尿嘧啶;联合组(24例),静脉输注奥沙利铂和氟尿嘧啶。所有患者均接受放射治疗,经过2个疗程后评估了疗效和安全性。 MTT法用于观察人直肠癌细胞增殖的抑制作用。比较细胞增殖和敏化率。经过2个疗程的治疗,完全缓解(CR),部分缓解(PR),稳定疾病(SD),疾病进展(PD)和疾病控制率(DCR)没有差异。联合治疗组的缓解率(RR)高于奥沙利铂和氟尿嘧啶组(P <0.05),奥沙利铂和氟尿嘧啶组之间无差异(P> 0.05)。联合治疗组中性粒细胞减少症的发生率高于氟尿嘧啶组(P <0.05)。联合治疗组的OD值低于奥沙利铂和氟尿嘧啶组(P <0.05)。联合组SW837细胞的增殖能力明显低于奥沙利铂和氟尿嘧啶组(P <0.05)。组内敏化率比较表明,三组细胞在24、48、72 h的敏化率均高于12 h(P <0.05)。奥沙利铂和5-氟尿嘧啶的组合治疗老年直肠癌是安全有效的,可用于放射治疗的敏化。因此应在临床实践中推广。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号